400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2022-05-31
癌症新型疗法研究商
医药研发/制造
化学&生物药
2022-03-31
小分子抑制剂开发商
医药研发/制造
化学&生物药
2019-12-19
新型激酶抑制剂研发商
医药研发/制造
化学&生物药
Eshelman Ventures;
Eshelman Ventures;
Vida Ventures;
Vida Ventures;
Nextech Invest;
奥博资本;
Foresite Capital
2016-07-12
癌症新型疗法研究商
医药研发/制造
化学&生物药
Healthlink Capital;
Healthlink Capital;
Eshelman Ventures;
Eshelman Ventures;
Centene;
TaiAn Technologies Corporation
2016-05-11
癌症新型疗法开发商
医药研发/制造
化学&生物药
鱼鹰资管;
鱼鹰资管;
Aju IB Investment;
Aju IB Investment;
Rock Springs Capital;
Eshelman Ventures;
Hatteras Venture Partners;
Lumira Capital;
MedImmune Ventures;
Mountain Group Capital;
RA Capital;
Franklin Templeton Investments;
Cowen Private Investments;
Tavistock Group
2015-02-05
癌症新型疗法开发商
医药研发/制造
化学&生物药
Eshelman Ventures;
Eshelman Ventures;
RA Capital;
RA Capital;
Lumira Capital;
Boxer Capital;
Hatteras Venture Partners;
MedImmune Ventures;
Mountain Group Capital
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10